RVNC Annual Total Liabilities
$630.06 M
+$60.76 M+10.67%
31 December 2023
Summary:
As of January 20, 2025, RVNC annual total liabilities is $630.06 million, with the most recent change of +$60.76 million (+10.67%) on December 31, 2023. During the last 3 years, it has risen by +$284.13 million (+82.13%). RVNC annual total liabilities is now at all-time high.RVNC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Quarterly Total Liabilities
$624.59 M
+$57.00 K+0.01%
30 September 2024
Summary:
As of January 20, 2025, RVNC quarterly total liabilities is $624.59 million, with the most recent change of +$57.00 thousand (+0.01%) on September 30, 2024. Over the past year, it has dropped by -$14.09 million (-2.21%). RVNC quarterly total liabilities is now -2.21% below its all-time high of $638.69 million, reached on September 30, 2023.RVNC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | -2.2% |
| 3 y3 years | +82.1% | +35.3% |
| 5 y5 years | +680.5% | +445.4% |
RVNC Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.2% | -2.2% | +35.0% |
| 5 y | 5-year | at high | +448.9% | -2.2% | +444.1% |
| alltime | all time | at high | +3813.4% | -2.2% | +4992.9% |
Revance Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $624.59 M(+0.0%) |
| June 2024 | - | $624.54 M(+2.9%) |
| Mar 2024 | - | $606.79 M(-3.7%) |
| Dec 2023 | $630.06 M(+10.7%) | $630.06 M(-1.4%) |
| Sept 2023 | - | $638.69 M(+11.9%) |
| June 2023 | - | $570.75 M(-0.6%) |
| Mar 2023 | - | $574.47 M(+0.9%) |
| Dec 2022 | $569.30 M(+23.0%) | $569.30 M(+0.6%) |
| Sept 2022 | - | $565.88 M(+0.2%) |
| June 2022 | - | $564.51 M(-8.1%) |
| Mar 2022 | - | $614.00 M(+32.7%) |
| Dec 2021 | $462.69 M(+33.8%) | $462.69 M(+0.2%) |
| Sept 2021 | - | $461.67 M(+1.5%) |
| June 2021 | - | $454.64 M(+5.3%) |
| Mar 2021 | - | $431.70 M(+24.8%) |
| Dec 2020 | $345.93 M(+201.3%) | $345.93 M(+2.0%) |
| Sept 2020 | - | $339.29 M(+5.9%) |
| June 2020 | - | $320.46 M(+12.6%) |
| Mar 2020 | - | $284.55 M(+147.9%) |
| Dec 2019 | $114.80 M(+42.2%) | $114.80 M(+0.2%) |
| Sept 2019 | - | $114.53 M(+6.7%) |
| June 2019 | - | $107.35 M(+3.8%) |
| Mar 2019 | - | $103.37 M(+28.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $80.73 M(+200.6%) | $80.73 M(+58.4%) |
| Sept 2018 | - | $50.95 M(+3.4%) |
| June 2018 | - | $49.27 M(+2.3%) |
| Mar 2018 | - | $48.14 M(+79.3%) |
| Dec 2017 | $26.85 M(-1.6%) | $26.85 M(-1.0%) |
| Sept 2017 | - | $27.13 M(-1.9%) |
| June 2017 | - | $27.66 M(-10.1%) |
| Mar 2017 | - | $30.78 M(+12.8%) |
| Dec 2016 | $27.29 M(+20.9%) | $27.29 M(+4.4%) |
| Sept 2016 | - | $26.14 M(+23.1%) |
| June 2016 | - | $21.23 M(-4.1%) |
| Mar 2016 | - | $22.15 M(-1.9%) |
| Dec 2015 | $22.57 M(+40.2%) | $22.57 M(-2.5%) |
| Sept 2015 | - | $23.16 M(+3.5%) |
| June 2015 | - | $22.38 M(+82.4%) |
| Mar 2015 | - | $12.26 M(-23.8%) |
| Dec 2014 | $16.10 M(-91.1%) | $16.10 M(-23.4%) |
| Sept 2014 | - | $21.01 M(-15.3%) |
| June 2014 | - | $24.81 M(-12.1%) |
| Mar 2014 | - | $28.23 M(-84.3%) |
| Dec 2013 | $180.19 M(-21.7%) | $180.19 M(+337.8%) |
| Sept 2013 | - | $41.16 M(-82.1%) |
| Dec 2012 | $230.15 M(+17.8%) | $230.15 M |
| Dec 2011 | $195.41 M | - |
FAQ
- What is Revance Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Revance Therapeutics?
- What is Revance Therapeutics annual total liabilities year-on-year change?
- What is Revance Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Revance Therapeutics?
- What is Revance Therapeutics quarterly total liabilities year-on-year change?
What is Revance Therapeutics annual total liabilities?
The current annual total liabilities of RVNC is $630.06 M
What is the all time high annual total liabilities for Revance Therapeutics?
Revance Therapeutics all-time high annual total liabilities is $630.06 M
What is Revance Therapeutics annual total liabilities year-on-year change?
Over the past year, RVNC annual total liabilities has changed by +$60.76 M (+10.67%)
What is Revance Therapeutics quarterly total liabilities?
The current quarterly total liabilities of RVNC is $624.59 M
What is the all time high quarterly total liabilities for Revance Therapeutics?
Revance Therapeutics all-time high quarterly total liabilities is $638.69 M
What is Revance Therapeutics quarterly total liabilities year-on-year change?
Over the past year, RVNC quarterly total liabilities has changed by -$14.09 M (-2.21%)